Principal Scientist, Pharmacology (Oncology)

Principal Scientist, Pharmacology (Oncology) 

  HireMinds is seeking talent for a new client that is working in novel precision oncology approaches. In this role you will work with an amazing leader and help grow the in vivo pharmacology function for a robust pipeline on oncology and immuno-oncology pipeline projects. You will bring critical insight in design of in vivo models and translational biomarker studies towards IND enabling programs. You will have the ability to help project teams make go/no-go decisions and be instrumental in success of the future clinical programs. You will be able to work cross-functionally with peers in chemistry, biology, and other contributing functions and with external CRO partners in successful program decision making. If this sounds like an exciting next step for your career contact Chris Clancy and the HireMinds Biotech team to learn more. 

You Will Be Responsible For: 

•    Leading Pharmacology function on multiple oncology projects
•    Study design on key pharmacology models in the oncology and immune-oncology space
•    Working collaboratively with external academic and CRO partners in guiding pharmacology, PK/PD, and biomarker studies
•    Innovating the pipeline and serve as a SME on all in vivo matters 
•    Driving IND enabling studies and biomarker progression from preclinical to clinical stages

You Will Bring the Following Qualifications: 

•    Ph.D. in Pharmacology or Cellular Biology with 7+ years of Biotech or Pharmaceutical setting. 
•    In vivo pharmacology modeling expertise with a variety of oncology or immune-oncology (syngeneic or xenograft)
•    Expertise in PK/PD profiling and biomarker design in ushering studies to IND stage
•    Strengths in leading project teams from a pharmacology standpoint with go/no-go decision making
•    Ability to adapt to a growing biotech organizations evolving priorities and demands 
•    Professional communication skills with ability to present ideas and effect change within the organization 
•    Organized style in writing pharmacology sections and contributing to clinical stage filings
•    Ability to identify top CROs for a variety of cancer pathways and modeling studies